Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 5;33(2):135-145.
doi: 10.4103/tcmj.tcmj_86_20. eCollection 2021 Apr-Jun.

Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes

Orsu Prabhakar  1 , Mylipilli Bhuvaneswari  1
Affiliations
Review

Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes

Orsu Prabhakar et al. Tzu Chi Med J. .

Abstract

Nonalcoholic fatty liver disease (NAFLD) is considered as the hepatic evidence of insulin resistance which is the hallmark of type 2 diabetes. NAFLD is considered as the risk factor for developing type 2 diabetes and has a high frequency of occurrence in those with existing type 2 diabetes. Compared with patients with only NAFLD or type 2 diabetes, these patients show a poor metabolic profile and increase mortality. Hence, effective treatment strategies are necessary. Here, we review the role of diet and lifestyle modification in the management of NAFLD and type 2 diabetes. Based on the available studies, it has been shown that the addition of any kind of physical activity or exercise is beneficial for patients with both NAFLD and type 2 diabetes. Proper dietary management leads to weight loss are also effective in improving metabolic parameters in patients with both NAFLD and type 2 diabetes. In conclusion, it is clear that increasing physical activity or exercise is effective in improving metabolic parameters in patients who are suffering with both NAFLD and type 2 diabetes.

Keywords: Hepatic steatosis; Insulin resistant; Nonalcoholic fatty liver disease; Physical activity; Type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Pathogenesis and treatment of nonalcoholic fatty liver disease
Figure 2
Figure 2
Role of diet in the management of nonalcoholic fatty liver disease
Figure 3
Figure 3
Different therapeutic approaches of nonalcoholic fatty liver disease
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology. 2004;40:1387–95. - PubMed
    1. Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65:1096–108. - PMC - PubMed
    1. Pi-Sunyer FX. The obesity epidemic: Pathophysiology and consequences of obesity. Obes Res. 2002;10(Suppl 2):97S–104S. - PubMed
    1. Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis. 2004;8:535–47, viii. - PubMed
    1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, And Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5. - PubMed

LinkOut - more resources